Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every funding round, exec hire, M&A move, contract, and sentiment shift on Orbital Therapeutics — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Rna Medicines Provider Orbital Therapeutics Scores $270M Series A

PRIVATEApr 26, 2023•about 3 years ago

Amount Raised

$270 Million

Round Type

series a

Cambridge

Investors

Arch Venture Partners

Description

ARCH Venture Partners led the round.

Company Information

Company

Orbital Therapeutics

Location

Cambridge, Maryland, United States

About

Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding RNAi therapeutics) to treat human disease in ways that were not previously possible. We’re building a first-in-kind platform designed to sit at the intersection of RNA technology delivery methods, data science and automation to develop an expansive portfolio of medicines, initially focused in the areas of vaccines, immunomodulation, protein replacement and regenerative medicine. Founded by experts in the fields of genetic medicine and RNA development and delivery, we have a dynamic operational structure designed to harness the ingenuity of a deep and diverse team of scientists, drug developers and business leaders.

Predictive Intelligence
Strategic

ML-powered predictions for Orbital Therapeutics's next move

Learn about Strategic plan

Related People

Suggested for you
1 contact

Sign in to view contact details

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, FundzIQ™ for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching Orbital Therapeutics? See every signal — funding, hires, M&A, contracts, sentiment.

See plans